Further to its letter dated February 17, 2026 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biocon has informed that it enclosed the Investor Presentation with respect to the Analyst(s)/Institutional Investor(s) meets scheduled to be held on February 25, 2026 and February 26, 2026. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
